These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35281431)

  • 1. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.
    Depuydt E; Broeckx SY; Chiers K; Patruno M; Da Dalt L; Duchateau L; Saunders J; Pille F; Martens A; Van Hecke L; Spaas JH
    Front Vet Sci; 2021; 8():789293. PubMed ID: 35281431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment of equine allogeneic tenogenic primed mesenchymal stem cells in horses with naturally occurring tendon and ligament injuries.
    Carlier S; Depuydt E; Van Hecke L; Martens A; Saunders J; Spaas JH
    Front Vet Sci; 2024; 11():1282697. PubMed ID: 38468694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evaluation of Equine Allogeneic Tenogenic Primed Mesenchymal Stem Cells in a Surgically Induced Superficial Digital Flexor Tendon Lesion Model.
    Depuydt E; Broeckx SY; Van Hecke L; Chiers K; Van Brantegem L; van Schie H; Beerts C; Spaas JH; Pille F; Martens A
    Front Vet Sci; 2021; 8():641441. PubMed ID: 33748217
    [No Abstract]   [Full Text] [Related]  

  • 4. Equine allogeneic tenogenic primed mesenchymal stem cells: A clinical field study in horses suffering from naturally occurring superficial digital flexor tendon and suspensory ligament injuries.
    Carlier S; Depuydt E; Suls M; Bocqué C; Thys J; Vandenberghe A; Martens A; Saunders J; Hellmann K; Braun G; Beerts C; Spaas JH
    Equine Vet J; 2024 Sep; 56(5):924-935. PubMed ID: 37847100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the functional properties of tenogenic primed mesenchymal stem cells in ex vivo equine tendon and ligament explants: A preliminary study.
    Depuydt E; Chiers K; Van Hecke L; Saunders J; Martens A; Pille F; Spaas JH
    Stem Cell Res; 2022 Dec; 65():102963. PubMed ID: 36395687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity analysis of BPV-1 positive equine sarcoid-derived cultured fibroblasts.
    Gysens L; Depuydt E; Patruno M; Haspeslagh M; Spaas JH; Martens A
    Vet Immunol Immunopathol; 2023 Feb; 256():110547. PubMed ID: 36621059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical follow-up of horses treated with allogeneic equine mesenchymal stem cells derived from umbilical cord blood for different tendon and ligament disorders.
    Van Loon VJ; Scheffer CJ; Genn HJ; Hoogendoorn AC; Greve JW
    Vet Q; 2014; 34(2):92-7. PubMed ID: 25072527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
    Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
    Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemic cellular immune response against allogeneic mesenchymal stem cells is influenced by inflammation, differentiation and MHC compatibility:
    Cequier A; Vázquez FJ; Vitoria A; Bernad E; Fuente S; Serrano MB; Zaragoza MP; Romero A; Rodellar C; Barrachina L
    Front Vet Sci; 2024; 11():1391872. PubMed ID: 38957800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.
    Geburek F; Roggel F; van Schie HTM; Beineke A; Estrada R; Weber K; Hellige M; Rohn K; Jagodzinski M; Welke B; Hurschler C; Conrad S; Skutella T; van de Lest C; van Weeren R; Stadler PM
    Stem Cell Res Ther; 2017 Jun; 8(1):129. PubMed ID: 28583184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study.
    Geburek F; Mundle K; Conrad S; Hellige M; Walliser U; van Schie HT; van Weeren R; Skutella T; Stadler PM
    Stem Cell Res Ther; 2016 Feb; 7():21. PubMed ID: 26830812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.
    Owens SD; Kol A; Walker NJ; Borjesson DL
    Stem Cells Int; 2016; 2016():5830103. PubMed ID: 27648075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic mesenchymal stem cell transplantation in healthy equine superficial digital flexor tendon: A study of the local inflammatory response.
    Brandão JS; Alvarenga ML; Pfeifer JPH; Dos Santos VH; Fonseca-Alves CE; Rodrigues M; Laufer-Amorim R; Castillo JAL; Alves ALG
    Res Vet Sci; 2018 Jun; 118():423-430. PubMed ID: 29715649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses.
    Burk J; Wittenberg-Voges L; Schubert S; Horstmeier C; Brehm W; Geburek F
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
    Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
    Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
    Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
    Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
    Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
    Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.
    Berglund AK; Schnabel LV
    Equine Vet J; 2017 Jul; 49(4):539-544. PubMed ID: 27862236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse.
    Ricco S; Renzi S; Del Bue M; Conti V; Merli E; Ramoni R; Lucarelli E; Gnudi G; Ferrari M; Grolli S
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):61-8. PubMed ID: 24046950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.